Experimental pharmacology in precision medicine
Pharmacol Res Perspect
.
2023 Dec;11(6):e01147.
doi: 10.1002/prp2.1147.
Authors
Alicja Urbaniak
1
,
Kenneth E Thummel
2
,
Ayoade N Alade
2
,
Allan E Rettie
2
,
Bhagwat Prasad
3
,
Amedeo De Nicolò
4
,
Jennifer H Martin
5
,
David N Sheppard
6
,
Michael F Jarvis
7
Affiliations
1
Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
2
School of Pharmacy, University of Washington, Seattle, Washington, USA.
3
Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA.
4
University of Turin, Turin, Italy.
5
The University of Newcastle Hunter Medical Research Institute, New Lambton, New South Wales, Australia.
6
School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
7
Pharmaceutical Sciences, University of Illinois-Chicago, Chicago, Illinois, USA.
PMID:
37885364
PMCID:
PMC10603287
DOI:
10.1002/prp2.1147
No abstract available
MeSH terms
Drug Discovery
Pharmacogenetics*
Precision Medicine*
Grants and funding
KL2 TR003108/TR/NCATS NIH HHS/United States
MR/S00274X/1/MRC_/Medical Research Council/United Kingdom
P01 GM116691/GM/NIGMS NIH HHS/United States
R01 HD081299/HD/NICHD NIH HHS/United States